Publications

  1. Urolithin A mitigates cisplatin-induced nephrotoxicity by inhibiting renal inflammation and apoptosis in an experimental rat model. Guada M, Ganugula R, Vadhanam M, Kumar MNVR. JPharmacol Exp Ther. 2017 Oct;363(1):58-65. doi: 10.1124/jpet.117.242420. Epub 2017 Aug 7. PMID: 28784820 (Cover Article)
  2. Ex Vivo rat eye model for investigating transport of next generation precision-polyester nanosystems. Ganugula R, Arora M, Kumar MNVR. ACS Appl Mater Interfaces. 2017 Aug 9;9(31):25668-25671. doi: 10.1021/acsami.7b07896. Epub 2017 Jul 26. PMID: 28737886
  3. Nano-curcumin safely prevents streptozotocin-induced inflammation and apoptosis in pancreatic beta cells for effective management of Type 1 diabetes mellitus. Ganugula R, Arora M, Jaisamut P, Wiwattanapatapee R, Jørgensen HG, Venkatpurwar VP, Zhou B, Rodrigues Hoffmann A, Basu R, Guo S, Kumar MNVR. Br J Pharmacol. 2017 Jul;174(13):2074-2084. doi: 10.1111/bph.13816. Epub 2017 May 30. PMID: 28409821.
  4. Next generation precision-polyesters enabling optimization of ligand-receptor stoichiometry for modular drug delivery. Ganugula R, Arora M, Saini P, Guada M, Kumar MNVR. J Am Chem Soc. 2017 May 31;139(21):7203-7216. doi: 10.1021/jacs.6b13231. Epub 2017 Apr 19. PMID: 28395139 (Cover Article)
  5. Noncompetitive active transport exploiting intestinal transferrin receptors for oral delivery of proteins by tunable nanoplatform. Ganugula R, Arora M, Guada M, Saini P, Kumar MNVR. ACS Macro Lett. 6 (2), 161-164. DOI: 10.1021/acsmacrolett.7b00035. (Cover Article)
  6. The next generation non-competitive active polyester nanosystems for transferrin receptor-mediated peroral transport utilizing gambogic acid as a ligand. Saini P, Ganugula R, Arora M, Kumar MNVR.Sci Rep. 2016 Jul 8;6:29501. doi: 10.1038/srep29501.